Cadrenal Therapeutics, Inc. — Form D

Cadrenal Therapeutics, Inc. of PONTE VEDRA, FL, a company, filed a Form D exempt-offering notice with the SEC on 2022-07-25. The offering totals $2.0M, of which $150K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
JOHN R MURPHYDirectorPONTE VEDRA, FL
LEE S GOLDENDirectorPONTE VEDRA, FL
JEFFREY K COLEExecutive OfficerPONTE VEDRA, FL
QUANG X PHAMDirectorPONTE VEDRA, FL
QUANG X PHAMExecutive OfficerPONTE VEDRA, FL
JAMES J FERGUSONExecutive OfficerPONTE VEDRA, FL
GLYNN J WILSONDirectorPONTE VEDRA, FL
STEVEN J ZELENKOFSKEDirectorPONTE VEDRA, FL
Jeffrey ColeRelated PersonToronto, A6
John MurphyDirectorBeaver Falls, PA
Steven W ZelenkofskeDirectorPonte Vedra, FL
Jeff W ColeExecutive OfficerPonte Vedra, FL
Glynn W WilsonDirectorPonte Vedra, FL
Matthew SzotExecutive OfficerPonte Vedra, FL
Matthew SzotRelated PersonPonte Vedra, FL
Douglas W LosordoExecutive OfficerPonte Vedra, FL
Quang PhamDirectorPonte Vedra, FL
Quang PhamExecutive OfficerPonte Vedra, FL
Robert W LisickiDirectorPonte Vedra, FL
Glynn WilsonDirectorPonte Vedra, FL
Glynn WilsonRelated PersonPonte Vedra, FL
STEVEN ZELENKOFSKEDirectorPonte Vedra, FL
STEVEN ZELENKOFSKERelated PersonPonte Vedra, FL
Douglas LosordoExecutive OfficerPONTE VEDRA, FL
JAMES FERGUSONRelated PersonPonte Vedra, FL

Other filings by this issuer (6)

FiledFormOfferingSold
2026-07-15D$8.8M$8.8M
2026-04-06D$7.9M$7.9M
2025-12-31D$4.4M$4.4M
2024-11-14D$9.4M$9.4M
2023-07-18D$7.5M$7.5M
2022-12-08D$1.0M$250K

More